Effect of phentolamine on the somatostatin-induced inhibition of glucagon and insulin secretion (Q40161342)

18 September 2017

title

Effect of phentolamine on the somatostatin-induced inhibition of glucagon and insulin secretion (English)

1 reference

https://api.crossref.org/works/10.1016/0026-0495(78)90133-6

10 January 2023

1 reference

1 reference

https://api.crossref.org/works/10.1016/0026-0495(78)90133-6

10 January 2023

author name string

A. Kaneto

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:209286

10 January 2023

H. Kajinuma

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:209286

10 January 2023

T. Kaneko

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:209286

10 January 2023

K. Kosaka

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:209286

10 January 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=209286

10 January 2023

publication date

1 August 1978

1 reference

full work available at URL

18 September 2017

number of pages

10

1 reference

based on heuristic

inferred from page(s)

https://api.elsevier.com/content/article/PII:0026049578901336?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0026-0495(78)90133-6

https://api.elsevier.com/content/article/PII:0026049578901336?httpAccept=text/plain

10 January 2023

1 reference

https://api.crossref.org/works/10.1016/0026-0495(78)90133-6

10 January 2023

1 reference

18 September 2017

volume

27

1 reference

18 September 2017

issue

8

1 reference

18 September 2017

page(s)

901-910

1 reference

Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth Hormone

18 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0026-0495(78)90133-6

Effect of somatostatin in patients with acromegaly: suppression of growth hormone, prolactin, insulin and glucose levels

10 January 2023

2

1 reference

https://api.crossref.org/works/10.1016/0026-0495(78)90133-6

Action of growth-hormone-release inhibitory hormone in healthy men and in acromegaly

10 January 2023

3

1 reference

https://api.crossref.org/works/10.1016/0026-0495(78)90133-6

Inhibition by somatostatin on the release of TSH induced in man by thyrotropin-releasing factor

10 January 2023

4

1 reference

https://api.crossref.org/works/10.1016/0026-0495(78)90133-6

Inhibition of gastrin and gastric-acid secretion by growth-hormone release-inhibiting hormone

10 January 2023

6

1 reference

https://api.crossref.org/works/10.1016/0026-0495(78)90133-6

Inhibition of insulin secretion by somatostatin

10 January 2023

7

1 reference

https://api.crossref.org/works/10.1016/0026-0495(78)90133-6

Somatostatin: Hypothalamic Inhibitor of the Endocrine Pancreas

10 January 2023

8

1 reference

https://api.crossref.org/works/10.1016/0026-0495(78)90133-6

Letter: Somatostatin action on pancreas

10 January 2023

9

1 reference

https://api.crossref.org/works/10.1016/0026-0495(78)90133-6

Acute suppression of insulin and glucose levels by synthetic somatostatin in normal human subjects

10 January 2023

10

1 reference

https://api.crossref.org/works/10.1016/0026-0495(78)90133-6

Effect of somatostatin on plasma glucose and insulin responses to glucagon and tolbutamide in man

10 January 2023

11

1 reference

https://api.crossref.org/works/10.1016/0026-0495(78)90133-6

Dose-response study of the inhibiting effect of somatostatin on growth hormone and insulin secretion in normal subjects and acromegalic patients

10 January 2023

12

1 reference

https://api.crossref.org/works/10.1016/0026-0495(78)90133-6

Effects of growth-hormone release-inhibiting hormone on circulating glucagon, insulin, and growth hormone in normal, diabetic, acromegalic, and hypopituitary patients.

10 January 2023

13

1 reference

https://api.crossref.org/works/10.1016/0026-0495(78)90133-6

Effects of somatostatin on plasma glucose and glucagon levels in human diabetes mellitus. Pathophysiologic and therapeutic implications.

10 January 2023

14

1 reference

https://api.crossref.org/works/10.1016/0026-0495(78)90133-6

Glucagon control of fasting glucose in man.

10 January 2023

15

1 reference

https://api.crossref.org/works/10.1016/0026-0495(78)90133-6

Somatostatin-induced changes in insulin and glucagon secretion in normal and diabetic dogs

10 January 2023

16

1 reference

https://api.crossref.org/works/10.1016/0026-0495(78)90133-6

Inhibition of pancreatic glucagon responses to arginine by somatostatin in normal man and in insulin-dependent diabetics

10 January 2023

17

1 reference

https://api.crossref.org/works/10.1016/0026-0495(78)90133-6

Somatostatin blockade of acute and chronic stimuli of the endocrine pancreas and the consequences of this blockade on glucose homeostasis

10 January 2023

18

1 reference

https://api.crossref.org/works/10.1016/0026-0495(78)90133-6

Comparison of Cyclic and Linear Forms of Somatostatin in the Inhibition of Growth Hormone, Insulin and Glucagon Secretion1

10 January 2023

19

1 reference

https://api.crossref.org/works/10.1016/0026-0495(78)90133-6

Inhibition of Glucagon and Insulin Secretion by Somatostatin in the Rat Pancreas Perfusedin Situ

10 January 2023

20

1 reference

https://api.crossref.org/works/10.1016/0026-0495(78)90133-6

Inhibitory Action of Somatostatin on Pancreatic α and β Cell Function1

10 January 2023

21

1 reference

https://api.crossref.org/works/10.1016/0026-0495(78)90133-6

Biological activity of somatostatin and somatostatin analogs on inhibtion of arginine-induced insulin and glucagon release in the rat

10 January 2023

22

1 reference

https://api.crossref.org/works/10.1016/0026-0495(78)90133-6

Reversal of somatostatin inhibition of insulin secretion by calcium

10 January 2023

23

1 reference

https://api.crossref.org/works/10.1016/0026-0495(78)90133-6

Direct inhibition of insulin secretion by synthetic somatostatin

10 January 2023

25

1 reference

https://api.crossref.org/works/10.1016/0026-0495(78)90133-6

Somatostatin Inhibition of Epinephrine-Induced Glucagon Secretion

10 January 2023

26

1 reference

https://api.crossref.org/works/10.1016/0026-0495(78)90133-6

Glucagon secretion from the perfused rat pancreas. Studies with glucose and catecholamines

10 January 2023

27

1 reference

https://api.crossref.org/works/10.1016/0026-0495(78)90133-6

Somatostatin inhibits insulin and glucagon release by monolayer cell cultures of rat endocrine pancreas

10 January 2023

28

1 reference

https://api.crossref.org/works/10.1016/0026-0495(78)90133-6

Somatostatin Inhibition of Glucose-, Tolbutamide-, Theophylline-, Cytochalasin B-, and Calcium-Stimulated Insulin Release in Monolayer Cultures of Rat Endocrine Pancreas

10 January 2023

29

1 reference

https://api.crossref.org/works/10.1016/0026-0495(78)90133-6

Studies on the inhibitory effect of somatostatin on glucose induced insulin release in the isolated perfused rat pancreas

10 January 2023

30

1 reference

https://api.crossref.org/works/10.1016/0026-0495(78)90133-6

Somatostatin inhibition of insulin release from freshly isolated and organ cultured rat islets of langerhans in vitro

10 January 2023

31

1 reference

https://api.crossref.org/works/10.1016/0026-0495(78)90133-6

Inhibition by Somatostatin of Glucagon and Insulin Release from the Perfused Rat Pancreas in Response to Arginine, Isoproterenol and Theophylline: Evidence for a Preferential Effect on Glucagon Secretion

10 January 2023

32

1 reference

https://api.crossref.org/works/10.1016/0026-0495(78)90133-6

Somatostatin inhibition of insulin and glucagon secretion in rat islet culture: reversal by ionophore A23187

10 January 2023

33

1 reference

https://api.crossref.org/works/10.1016/0026-0495(78)90133-6

Does somatostatin inhibition of insulin secretion involve two mechanisms of action?

10 January 2023

34

1 reference

https://api.crossref.org/works/10.1016/0026-0495(78)90133-6

Effect of somatostatin on pancreatic endocrine--experiment by somatostatin infusion into the pancreaticoduodenal artery in dogs--(author's transl)

10 January 2023

35

1 reference

https://api.crossref.org/works/10.1016/0026-0495(78)90133-6

Electron microscopic immunohistochemical localization of growth hormone-release inhibiting hormone (somatostatin) in the rat median eminence

10 January 2023

36

1 reference

https://api.crossref.org/works/10.1016/0026-0495(78)90133-6

Growth-hormone release-inhibiting hormone in gastrointestinal and pancreatic D cells

10 January 2023

38

1 reference

https://api.crossref.org/works/10.1016/0026-0495(78)90133-6

Evidence for the D-cell of the pancreas secreting somatostatin

10 January 2023

40

1 reference

https://api.crossref.org/works/10.1016/0026-0495(78)90133-6

Ultrastructural localization of somatostatin in pancreatic islets of the rat

10 January 2023

41

1 reference

https://api.crossref.org/works/10.1016/0026-0495(78)90133-6

Effect of alpha adrenoreceptor stimulants infused intrapancreatically on glucagon and insulin secretion

10 January 2023

42

1 reference

https://api.crossref.org/works/10.1016/0026-0495(78)90133-6

Stimulation of glucagon and insulin secretion by acetylcholine infused intrapancreatically.

10 January 2023

43

1 reference

https://api.crossref.org/works/10.1016/0026-0495(78)90133-6

Stimulation of Insulin Secretion by Parasympathomimetic Agents

10 January 2023

44

1 reference

https://api.crossref.org/works/10.1016/0026-0495(78)90133-6

Wick Chromatography for Rapid and Reliable Immunoassay of Insulin, Glucagon and Growth Hormone

10 January 2023

45

1 reference

https://api.crossref.org/works/10.1016/0026-0495(78)90133-6

Neural control of the endocrine pancreas

10 January 2023

48

1 reference

https://api.crossref.org/works/10.1016/0026-0495(78)90133-6

Studies on the mechanism of somatostatin action on insulin release in man. I. Effect of blockade of alpha-adrenergic receptors

10 January 2023

50

1 reference

https://api.crossref.org/works/10.1016/0026-0495(78)90133-6

Phentolamine blocks the somatostatin-mediated inhibition of insulin secretion

10 January 2023

51

1 reference

https://api.crossref.org/works/10.1016/0026-0495(78)90133-6

Growth hormone and insulin release after arginine: indifference to hyperglycemia and epinephrine

10 January 2023

52

1 reference

https://api.crossref.org/works/10.1016/0026-0495(78)90133-6

Metabolic response to simultaneous infusion of epinephrine and Propranolol in obese adolescents

10 January 2023

53

1 reference

https://api.crossref.org/works/10.1016/0026-0495(78)90133-6

Role of glucose in arginine-induced insulin release in man

10 January 2023

54

1 reference

https://api.crossref.org/works/10.1016/0026-0495(78)90133-6

Effect of Epinephrine on Insulin Release in Man induced by Secretin

10 January 2023

55

1 reference

https://api.crossref.org/works/10.1016/0026-0495(78)90133-6

10 January 2023

Identifiers

1 reference

18 September 2017

1 reference